Hibernation Therapeutics is a biomedical company operating in the global cardiovascular and stroke markets.

Referred to as HiberTherapeutics™, the Company’s new pharmacological approach to cardiovascular and related drug development and other treatments has been developed from natural hibernation mechanisms studied by leading international scientists and medical practitioners and demonstrated in pre-clinical and clinical trials.

The HiberTherapeutics approach is strongly supported by a patented technology platform owned by Hibernation Therapeutics.

Hibernation Therapeutics Limited is an Australian unlisted public company.

Please contact us for more information on the company, its technology or investment or collaboration opportunities.